Your browser doesn't support javascript.
loading
Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012-2017).
Harker, Nadine; Lucas, Warren Covelé; Laubscher, Ria; Dada, Siphokazi; Myers, Bronwyn; Parry, Charles Dh.
Afiliação
  • Harker N; Alcohol Tobacco & Other Drug Research Unit, Medical Research Council, South Africa; School of Public Health, University of Cape Town, South Africa. Electronic address: nadine.harker@mrc.ac.za.
  • Lucas WC; Alcohol Tobacco & Other Drug Research Unit, Medical Research Council, South Africa.
  • Laubscher R; Biostatistics Unit, Medical Research Council, South Africa.
  • Dada S; Alcohol Tobacco & Other Drug Research Unit, Medical Research Council, South Africa.
  • Myers B; Alcohol Tobacco & Other Drug Research Unit, Medical Research Council, South Africa; Division of Addiction Psychiatry, Department of Psychiatry & Mental Health, University of Cape Town, South Africa.
  • Parry CD; Alcohol Tobacco & Other Drug Research Unit, Medical Research Council, South Africa; Department of Psychiatry, Stellenbosch University, South Africa.
Int J Drug Policy ; 83: 102839, 2020 09.
Article em En | MEDLINE | ID: mdl-32650228
INTRODUCTION: South Africa has seen a sharp increase in treatment admission trends for opioids despite beliefs that rates of opioid use remain low and do not represent a major problem. To advocate for the extension of Opioid Use Disorder (OUD) treatment and harm minimisation services in South Africa, better estimates of the extent of opioid use is needed. This paper responds to this need by describing (i) trends in treatment utilization for opioid-related problems in South Africa and (ii) differences in the profile of patients accessing treatment for different classes of opioids - heroin, 'nyaope' and codeine use. METHODS: Data were collected from 83 specialist treatment centres participating in the South African Community Epidemiology Network on Drug Use between 2012 and 2017. Descriptive analyses were conducted to describe the sociodemographic profile of patients and multiple logistic regression was used to explore socio-demographic and clinical factors associated with admission to treatment for opioid use disorders (OUD) . RESULTS: From January 2012 to December 2017, data from 11 2032 treatment episodes were collated. Of these, 20 319 (18.1%) were from patients admitted for an OUD. Over time, the proportion of overall opioid-related admissions increased significantly from 16.1% of all admissions in 2012 to 20.0% in 2017 (p <0.001). Data also suggests a significant increase in the overall proportion of patients reporting injection drug use, from 1.6% in 2013 to 3.5% in 2017 (p <0.001). Clear differences in employment status, referral sources between classes of opioids were also noted. CONCLUSION: Over the last 5 years, South Africa has seen an increase in the proportion of opioid related disorders (OUD) treatment admissions. Public health interventions, evidence-based harm reduction approaches and improving access to treatment are among the interventions urgently needed to reduce the harms associated with the increased use of opioids in South Africa.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Transtornos Relacionados ao Uso de Opioides Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Int J Drug Policy Assunto da revista: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Transtornos Relacionados ao Uso de Opioides Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Int J Drug Policy Assunto da revista: SAUDE PUBLICA / TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda